Clinical Trial Update: Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance

View source ↗

Summary

A completed clinical trial evaluating molecular subtyping of extensive-stage small cell lung cancer and its clinical significance. The study investigates how mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: SCLC,Extensive Stage | Status: COMPLETED